Cargando…

Advances in Histological and Molecular Classification of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a primary liver cancer characterized by hepatocellular differentiation. HCC is molecularly heterogeneous with a wide spectrum of histopathology. The prognosis of patients with HCC is generally poor, especially in those with advanced stages. HCC remains a diagnostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Joon Hyuk, Thung, Swan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526317/
https://www.ncbi.nlm.nih.gov/pubmed/37761023
http://dx.doi.org/10.3390/biomedicines11092582
_version_ 1785110993016193024
author Choi, Joon Hyuk
Thung, Swan N.
author_facet Choi, Joon Hyuk
Thung, Swan N.
author_sort Choi, Joon Hyuk
collection PubMed
description Hepatocellular carcinoma (HCC) is a primary liver cancer characterized by hepatocellular differentiation. HCC is molecularly heterogeneous with a wide spectrum of histopathology. The prognosis of patients with HCC is generally poor, especially in those with advanced stages. HCC remains a diagnostic challenge for pathologists because of its morphological and phenotypic diversity. However, recent advances have enhanced our understanding of the molecular genetics and histological subtypes of HCC. Accurate diagnosis of HCC is important for patient management and prognosis. This review provides an update on HCC pathology, focusing on molecular genetics, histological subtypes, and diagnostic approaches.
format Online
Article
Text
id pubmed-10526317
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105263172023-09-28 Advances in Histological and Molecular Classification of Hepatocellular Carcinoma Choi, Joon Hyuk Thung, Swan N. Biomedicines Review Hepatocellular carcinoma (HCC) is a primary liver cancer characterized by hepatocellular differentiation. HCC is molecularly heterogeneous with a wide spectrum of histopathology. The prognosis of patients with HCC is generally poor, especially in those with advanced stages. HCC remains a diagnostic challenge for pathologists because of its morphological and phenotypic diversity. However, recent advances have enhanced our understanding of the molecular genetics and histological subtypes of HCC. Accurate diagnosis of HCC is important for patient management and prognosis. This review provides an update on HCC pathology, focusing on molecular genetics, histological subtypes, and diagnostic approaches. MDPI 2023-09-20 /pmc/articles/PMC10526317/ /pubmed/37761023 http://dx.doi.org/10.3390/biomedicines11092582 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Choi, Joon Hyuk
Thung, Swan N.
Advances in Histological and Molecular Classification of Hepatocellular Carcinoma
title Advances in Histological and Molecular Classification of Hepatocellular Carcinoma
title_full Advances in Histological and Molecular Classification of Hepatocellular Carcinoma
title_fullStr Advances in Histological and Molecular Classification of Hepatocellular Carcinoma
title_full_unstemmed Advances in Histological and Molecular Classification of Hepatocellular Carcinoma
title_short Advances in Histological and Molecular Classification of Hepatocellular Carcinoma
title_sort advances in histological and molecular classification of hepatocellular carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526317/
https://www.ncbi.nlm.nih.gov/pubmed/37761023
http://dx.doi.org/10.3390/biomedicines11092582
work_keys_str_mv AT choijoonhyuk advancesinhistologicalandmolecularclassificationofhepatocellularcarcinoma
AT thungswann advancesinhistologicalandmolecularclassificationofhepatocellularcarcinoma